Clinical trial of effect on androgenic alopecia treated with decoction of Garden Balsam and Platycladus orientalis leaves

注册号:

Registration number:

ITMCTR2000004208

最近更新日期:

Date of Last Refreshed on:

2020-10-05

注册时间:

Date of Registration:

2020-10-05

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

透骨草-侧柏叶提取物治疗雄激素性秃发临床研究

Public title:

Clinical trial of effect on androgenic alopecia treated with decoction of Garden Balsam and Platycladus orientalis leaves

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于药对配伍机制下透骨草-侧柏叶煎剂对治疗雄激素性秃发实验及机制研究

Scientific title:

Androgenic alopecia treated by combination of Garden Balsam and Platycladus orientalis leaves: experimental and clinical research

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR2000038833 ; ChiMCTR2000004208

申请注册联系人:

项晶

研究负责人:

项晶

Applicant:

Jing Xiang

Study leader:

Jing Xiang

申请注册联系人电话:

Applicant telephone:

+86 18367340121

研究负责人电话:

Study leader's telephone:

+86 18367340121

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

715364446@qq.com

研究负责人电子邮件:

Study leader's E-mail:

715364446@qq.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

浙江省嘉兴市中山东路1501号

研究负责人通讯地址:

浙江省嘉兴市中山东路1501号

Applicant address:

1501 Zhongshan Road East, Jiaxing, Zhejiang

Study leader's address:

1501 Zhongshan Road East, Jiaxing, Zhejiang

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

嘉兴市中医医院

Applicant's institution:

Jiaxing Hospital of Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

2019KY0426

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

嘉兴市中医医院伦理委员会

Name of the ethic committee:

Ethics Committee of Jiaxing Hospital of Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2019/5/24 0:00:00

伦理委员会联系人:

金利民

Contact Name of the ethic committee:

Limin Jin

伦理委员会联系地址:

浙江省嘉兴市中山东路1501号

Contact Address of the ethic committee:

1501 Zhongshan Road East, Jiaxing, Zhejiang

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 573-82079137

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

嘉兴市中医医院

Primary sponsor:

Jiaxing Hospital of Chinese Medicine

研究实施负责(组长)单位地址:

浙江省嘉兴市中山东路1501号

Primary sponsor's address:

1501 Zhongshan Road East, Jiaxing, Zhejiang

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

浙江

市(区县):

嘉兴

Country:

China

Province:

Zhejiang

City:

Jiaxing

单位(医院):

嘉兴市中医医院

具体地址:

中山东路1501号

Institution
hospital:

Jiaxing Hospital of Chinese Medicine

Address:

1501 Zhongshan Road East

经费或物资来源:

浙江省中医药科技计划项目

Source(s) of funding:

Project of science and technology of Chinese medicine in Zhejiang Province

研究疾病:

雄激素性秃发

研究疾病代码:

Target disease:

Androgenic alopecia

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

验证透骨草-侧柏叶煎剂治疗雄激素性秃发的临床疗效。

Objectives of Study:

To investigate the clinical effect on androgenic alopecia treated with decoction of Garden Balsam and Platycladus orientalis leaves.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

1)符合雄激素性秃发诊断标准的患者; 2)年龄介于18岁至50岁之间; 3)心、肝、肾功能正常,不合并其他重大疾病; 4)参与本课题研究前2周内未接受过本病其他相关治疗;

Inclusion criteria

1) Patients who met the diagnostic criteria of androgenic alopecia; 2) The age ranged from 18 to 50 years; 3) The function of heart, liver and kidney was normal, and no other major disease; 4) No other related treatment was received within 2 weeks.

排除标准:

1)合并银屑病、头癣等其他可能影响该研究的皮肤病患者; 2)过敏体质或对本实验研究治疗药物过敏者; 3)曾接受过手术植发的患者。

Exclusion criteria:

1) Patients with psoriasis, tinea capitis and other skin diseases that may affect the study; 2) Allergic constitution or allergic to drugs in this experimental study; 3) Patients who have received surgical hair transplants.

研究实施时间:

Study execute time:

From 2020-10-15

To      2021-09-30

征募观察对象时间:

Recruiting time:

From 2020-10-15

To      2021-12-31

干预措施:

Interventions:

组别:

中药1组

样本量:

60

Group:

Herb one group

Sample size:

干预措施:

采用外涂透骨草-侧柏叶煎剂,每次3-5ml,均匀涂抹头部患处,并用手按摩3~5分钟,每日2次。

干预措施代码:

h1

Intervention:

Decoction of Garden Balsam and Platycladus orientalis leaves (3-5ml each time), evenly spread on the head, and massage with hands for 3-5 minutes, twice a day.

Intervention code:

组别:

对照组

样本量:

60

Group:

Control group

Sample size:

干预措施:

采用外涂5%米诺地尔酊(商品名:蔓迪,国药准字H20010714),每次1mL(约7喷),涂于头部患处,从患处的中心开始涂抹,并用手按摩3~5分钟,每日2次。

干预措施代码:

con

Intervention:

Apply 5% minoxidil tincture (National drug approval number: h20010714), 1ml each time (about 7 sprays) on head, and massage with hands for 3-5 minutes, twice a day.

Intervention code:

组别:

中药2组

样本量:

60

Group:

Herb two group

Sample size:

干预措施:

采用外涂透骨草-侧柏叶煎剂,每次3-5ml,均匀涂抹头部患处,并用手按摩3~5分钟,每日2次。外加口服透骨草-侧柏叶煎剂,每次100ml,饭后半小时服用,每日2次。

干预措施代码:

h2

Intervention:

Decoction of Garden Balsam and Platycladus orientalis leaves (3-5ml each time), evenly spread on the head, and massage with hands for 3-5 minutes, twice a day.Oral decoction of Garden Balsam and Platycladus orientalis leaves (100ml each time), half an hour after meal, twice a day.

Intervention code:

样本总量 Total sample size : 180

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

浙江

市(区县):

嘉兴

Country:

China

Province:

Zhejiang

City:

Jiaxing

单位(医院):

嘉兴市中医医院

单位级别:

三级甲等

Institution/hospital:

Jiaxing Hospital of Chinese Medicine

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

毛发的密度和直径测量

指标类型:

次要指标

Outcome:

Measurement of hair density and diameter

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

中国雄激素性秃发诊疗指南BASP分型法

指标类型:

主要指标

Outcome:

BASP scale from guidelines for diagnosis and treatment of androgenetic alopecia of China

Type:

Primary indicator

测量时间点:

首诊、治疗结束、治疗结束后6个月

测量方法:

Measure time point of outcome:

The first visit, the end of treatment and 6 months after the end of treatment

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

标本中文名:

尿液

组织:

Sample Name:

Urine

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

标本中文名:

毛囊

组织:

毛囊

Sample Name:

hair follicle

Tissue:

hair follicle

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

正在进行

Recruiting

年龄范围:

最小 18
Min age years
最大 50
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

Excel Random函数

Randomization Procedure (please state who generates the random number sequence and by what method):

Excel Random function

盲法:

暂不采用盲法,因为中药有气味、独特口感,很难实现双盲

Blinding:

Blind method is not applied, because the herbs has smell and unique taste.It is difficult to perform double-blind.

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

利用Dryad平台存储和管理数据,数据符合 CC0 1.0 Universal (CC0 1.0) Public Domain Dedication license。预计公开时间为2021.12。https://datadryad.org。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Using Dryad platform to store and manage data, the data is licensed under a cc01.0 universal (cc01.0) public domain determination license. The expected publication time is 2021.12. https://datadryad.o

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病历记录表严格按照本研究方案设计,并依靠腾讯问卷平台进行采集和记录(https://wj.qq.com)。电子采集和管理系统依靠Dryad平台(https://datadryad.org)

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case record form is designed using Tencent questionnaire (https://wj.qq.com). Electronic data capture and management is on Dryad (https://datadryad.org).

数据管理委员会:

Data Managemen Committee:

No

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above